Delivery Order SPE2DB20D2014-SPE2DB24FB28H

Award Date 3/8/24
Potential Completion Date 3/11/24
Potential Value $2.3K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,012.20, is for the delivery of 4,567,909,359 units of the HAVRIX 720 UNIT/0.5 ML SYRINGE 0.5ML vaccine. The contract has an ultimate completion date of April 16, 2025. AmerisourceBergen Drug Corp is the prime contractor, and there is no set-aside designation indicated. This delivery...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,157.45, is for the supply of 4,567,461,416 units of the HAVRIX 720 vaccine syringe 0.5 mL. The award does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,134.87 firm fixed-price contract is for the delivery of 4,567,982,890 units of the HAVRIX 720 vaccine syringe. This delivery order is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that AmerisourceBergen holds with DLA Troop Support Medical. This IDC provides a comprehensive...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp., a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,560,839 units of the HAVRIX 720 UNIT/0.5 ML SYRINGE 0.5ML vaccine, with a total ceiling value of $1,347.50. The contract has a firm fixed price pricing type and an ultimate completion date of May 8, 2023. This contract is not designated as a set-aside. AmerisourceBergen holds...
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The contract is for the delivery of HAVRIX 1,440 unit/mL syringes, a specialty pharmaceutical product. The total ceiling value of this delivery order is $3,811.00 with a period of performance through March 27, 2024. AmerisourceBergen Drug Corp has been awarded this delivery order under a larger indefinite delivery contract...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of HAVRIX 720 UNIT/0.5 ML SYRINGE 0.5ML, a vaccine product, with a ceiling value of $1,467.81 and a period of performance through January 22, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between AmerisourceBergen and the DLA Troop...
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the for-profit organization Amerisourcebergen Corporation. The contract has a potential value of $3,395.16 and a completion date of February 23, 2024. The contract is for the delivery of HAVRIX 720 unit/0.5 mL syringes. This award is part of a larger indefinite delivery contract (IDC) between DLA Troop Support Medical and...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of HAVRIX 720 UNIT/0.5 ML SYRINGE 0.5ML pharmaceutical products. The contract has a total ceiling value of $3,215.14 and is a firm fixed price delivery order with a period of performance through May 9, 2024. Amerisourcebergen is a major supplier of pharmaceuticals and medical supplies to the U.S. federal government, with expertise...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a global pharmaceutical sourcing and distribution services company. The contract is for the delivery of HAVRIX 720 UNIT/0.5 ML SYRINGE 0.5ML, a pharmaceutical product, with a ceiling value of $1,122.70 and a period of performance through March 19, 2024. This delivery order is issued under an Indefinite...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a leading global pharmaceutical distribution company, for the supply of 1,440 unit/mL Havrix syringes. The order has a ceiling value of $1,905.50 and a completion date of April 12, 2024. This delivery order is part of a larger, single-award indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with DLA, valued at up to $999,999,999.00 through December 31, 2025....
  • SPE2DB20D2014
    Indefinite Delivery Contract
  • SPE2DB20D2014-SPE2DB24FB28H
    Delivery Order

This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of 4,563,906,226 units of the HAVRIX 720 0.5 ML syringe vaccine. The contract has a ceiling value of $2,309.50 and a period of performance through March 11, 2024. No set-aside designation was used for this award.

AmerisourceBergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA valued at up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. This specific delivery order is issued against that overarching IDC contract.

Generated 6/7/24, 10:26 AM